The lack of follow-up endangers the results of a smoking cessation program

Authors

  • Raúl Godoy Mayoral Servicio de Neumología. Complejo Hospitalario Universitario de Albacete (CHUA). Albacete
  • Francisco Javier Callejas González Servicio de Neumología. Complejo Hospitalario Universitario de Albacete (CHUA). Albacete
  • Javier Cruz Ruiz FEA Neumología. Hospital General de Almansa. Albacete. Servicio de Cirugía Torácica. Complejo Hospitalario Universitario de Albacete (CHUA). Albacete
  • Marta Genovés Crespo Medicina Familiar y Comunitaria. Gerencia de Atención Integrada (GAI) de Albacete. Albacete
  • Ana Isabel Tornero Molina Servicio de Neumología. Complejo Hospitalario Universitario de Albacete (CHUA). Albacete
  • Pedro Juan Tárraga López Medicina Familiar y Comunitaria. Gerencia de Atención Integrada (GAI) de Albacete. Albacete

DOI:

https://doi.org/10.19230/jonnpr.2616

Keywords:

Smoking, abandonment, motivation, anti-tobacco treatment

Abstract

Introduction: Of the patients who come to the consultation to stop smoking, many do not return to the second consultation, so they do not initiate the treatment.

Objective: To assess the follow-up of a smoking cessation program and analyze the characteristics of this population.

Patients and Methods: We analyzed 1484 patients who attended the Specialized Smoking Treatment Unit of the University Hospital Complex of Albacete from January 1, 2008 to December 31, 2012, assessing  anthropometric and social characteristics. Statistical Analysis: Chi-square and Fisher's exact test were used  for qualitative variables and Student's t for quantitative variables and a logistic regression was performed to avoid confounding variables. The level of significance was established with p <0.05

Results: A total of 1484 patients were included in the study. Of these, 731 subjects abandoned the treatment without going to the second consultation, this is 49.26% of the total. In the logistic  regression model that was done, it was not observed that any variable had a significant influence.

Conclusion: There is an excess of patients who, despite waiting for time to attend a first appointment, do not continue. This is a failure that we must study

 

Downloads

Download data is not yet available.

References

Higes Martinez EB, Ramos Pinedo A, Nistal Rodriguez A. Tratamiento Integral del Tabaquismo. En: Manejo diagnóstico y tratamiento del tabaquismo en la práctica clínica diaria. Manual SEPAR de procedimientos 2015; 32:30-41.

Agencia de Evaluación de Tecnologías Sanitarias. Evaluación de la eficacia, efectividad y coste-efectividad de los distintos abordajes terapeúticos para dejar de fumar. Madrid: AETS del Instituto de Salud Carlos III. 2003

Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29-38.

Rábade Castedo C, Lama López A, Dablanca Pallares M. Aproximación diagnóstica del paciente fumador. En: Manejo diagnóstico y tratamiento del tabaquismo en la práctica clínica diaria. Manual SEPAR de procedimientos 2015; 32:9-29.

Ramos Pinedo A, Prieto Gómez E.Estudio clínico del fumador En: Tratado de tabaquismo Jiménez Ruiz CA. Fagerström KO. Madrid 3a Edición. 2011; 295–308.

Jiménez Ruiz CA, Barrueco Ferrero M, Solano Reina S, Torrecilla García M, Domínguez Grandal F, Díaz Maroto Muñoz JL, et al. Recomendaciones en el abordaje diagnóstico y terapéutico del tabaquismo. Documento de consenso . Arch Bronconeumol .2003; 39:35–41.

Ramos Pinedo A, De Higes Martínez E, García-Salmones Martín M. Diagnóstico clínico del tabaquismo En: Manual de Tabaquismo Solano Reina S, Jiménez Ruiz CA, Riesco Miranda Juan A. Ed. Respira. 2012; 61– 70.

Prochaska JO, Goldstein MG. Process of smoking cessation: Implications for clinicians. Clin Chest Med. 1991; 12:727–35.

Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. 2008. Available from: http://www.ncbi.nlm.nih.gov/books/NBK63952/

Encuesta sobre conocimientos, actitudes, creencias y conductas en relación al consumo de tabaco. Madrid: Comité Nacional de Prevención del tabaquismo. 2008.

Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009; 338:1024.

Hughes JR, Rennard SI, Fingar JR, Talbot SK, Callas PW, Fagerstrom KO. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res. 2011; 13:955–64.

Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013; 8:2850.

Myung SK, McDonnell DD, Kazinets G, Seo HG, Moskowitz JM. Effects of weband computer-based smoking cessation programs: Meta-analysis of randomi- zed controlled trials. Arch Intern Med. 2009; 169:929–37.

Salvador Manzano María, Ayesta Ayesta Francisco Javier. La Adherencia Terapéutica en el Tratamiento del Tabaquismo. Psychosocial Intervention [Internet]. 2009 Dic [citado 2018 Jun 10] ; 18( 3 ): 233- 244. Disponible en: http://scielo.isciii.es/scielo.php? script=sci_arttext&pid=S1132-05592009000300004&lng=es.

López PJT, Godoy R, Callejas FJ, Tornero AI, Montes JAR, et al. Pharmacoeconomic Analysis of the Therapies Used in the Treatment of Smoking in a Specialized Unit. J Pulm Respir Med 2016; 6: 347. doi:10.4172/2161-105X.1000347

Godoy Mayoral R, Genovés Crespo M, Callejas González FJ, Tornero Molina A, Tárraga López PJ y Rodríguez Montes JA. Abstinencia a los 3, 6, 9 y 12 meses en la consulta especializada de deshabituación tabáquica del Complejo Hospitalario Universitario de Albacete. Prev Tab. 2016;18(2):71-77

Anthenelli RM, Benowitz NL, West R, Aubin LS, Mcrae T, Lawrence D, et al. Neuropsychiatric safety and effi cacy of varenicline , bupropion , and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet. 2016; 6736:1–14.

Bello S, Chamorro H, Orellana MA, Cisternas L, Salinas M. Experiencia de un programa de cesación del tabaquismo en el Instituto Nacional del Tórax. Rev Chil Enferm Respir. 2015; 31: 94-100. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-73482015000200004&lng=es.

López Varela María Victorina, Anido Turquesa, Rovira Mabel, Goja Beatriz, Tubino Mariela, Alfonso Graciela et al . Factores asociados con la abstinencia y eficacia de un programa de cesación de tabaquismo. Rev. Méd. Urug. 2007 [citado 2018 Mar 26] ; 23: 25-33. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-03902007000100004&lng=es.

Published

2018-08-06